High prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (Gold I-II)

J. Padua, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, F. Quinones-Falconi, R. H. Sansores-Martinez (Mexico City/DF, Mexico)

Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Session: Mechanisms of respiratory infections: interaction between the pathogen and the host
Session type: Thematic Poster Session
Number: 2300
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Padua, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, F. Quinones-Falconi, R. H. Sansores-Martinez (Mexico City/DF, Mexico). High prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (Gold I-II). Eur Respir J 2008; 32: Suppl. 52, 2300

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Low blood eosinophil count is associated with gram-positive cocci infection and poor clinical outcomes in severe exacerbations of COPD
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Source: Eur Respir J 2013; 41: 1107-1115
Year: 2013



Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018


Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Source: Eur Respir J 2009; 34: 1072-1078
Year: 2009



The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa: resistance to common antibiotics
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001

Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015



The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 240-244
Year: 2007



Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Telithromycin displays high clinical efficacy in outpatients with mild to moderate community-acquired pneumonia caused by atypical/intracellular pathogens
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002

Antibacterial activity of telithromycin (TEL) and comparators against bacterial pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in the PROTEKT study 1999–2002
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004

Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013

Bacterial infections in patients with acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004

Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019